Canada markets closed

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.1500-0.2800 (-11.52%)
At close: 04:00PM EDT
2.1400 -0.01 (-0.47%)
After hours: 07:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.14M
Enterprise Value 1.58M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.23
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.14

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3-84.42%
S&P500 52-Week Change 322.36%
52 Week High 318.0000
52 Week Low 31.4000
50-Day Moving Average 32.1949
200-Day Moving Average 36.0118

Share Statistics

Avg Vol (3 month) 31.52M
Avg Vol (10 day) 37.95M
Shares Outstanding 52.86M
Implied Shares Outstanding 62.86M
Float 82.49M
% Held by Insiders 111.27%
% Held by Institutions 11.94%
Shares Short (Apr 15, 2024) 4189.63k
Short Ratio (Apr 15, 2024) 40.46
Short % of Float (Apr 15, 2024) 47.13%
Short % of Shares Outstanding (Apr 15, 2024) 46.64%
Shares Short (prior month Mar 15, 2024) 440.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 23, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 22, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-99.41%
Return on Equity (ttm)-178.52%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.46M
Net Income Avi to Common (ttm)-11.12M
Diluted EPS (ttm)-8.4800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.71M
Total Cash Per Share (mrq)1.65
Total Debt (mrq)150.55k
Total Debt/Equity (mrq)3.02%
Current Ratio (mrq)7.71
Book Value Per Share (mrq)3.88

Cash Flow Statement

Operating Cash Flow (ttm)-8.06M
Levered Free Cash Flow (ttm)-4.11M